211 related articles for article (PubMed ID: 2915868)
1. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
Trofatter KF; Howell ML; Greenberg CS; Hage ML
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
[TBL] [Abstract][Full Text] [Related]
2. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
[TBL] [Abstract][Full Text] [Related]
3. Detection of fibrin D-dimer in plasma and urine of pregnant women using Dimertest latex assay.
Trofatter KF; Trofatter MO; Caudle MR; Offutt DQ
South Med J; 1993 Sep; 86(9):1017-21. PubMed ID: 8367746
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic abnormalities in patients with severe preeclampsia.
Heilmann L; Rath W; Pollow K
Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
Gupta PK; Gupta M; Chatterjee T; Saxena R
Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
[TBL] [Abstract][Full Text] [Related]
7. Fibrin D-dimer in thrombogenic disorders.
Matsuo T; Kobayashi H; Kario K; Suzuki S
Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
[TBL] [Abstract][Full Text] [Related]
8. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
9. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
Hafter R; Schröck R; von Hugo R; Graeff H
Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
11. Coagulation index to distinguish severe preeclampsia from normal pregnancy.
Kobayashi T; Sumimoto K; Tokunaga N; Sugimura M; Nishiguchi T; Kanayama N; Terao T
Semin Thromb Hemost; 2002 Dec; 28(6):495-500. PubMed ID: 12536338
[TBL] [Abstract][Full Text] [Related]
12. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
13. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
Zhou H; Chen R; Liu X
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
[TBL] [Abstract][Full Text] [Related]
14. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
15. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
16. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.
Perry KG; Martin JN
Clin Obstet Gynecol; 1992 Jun; 35(2):338-50. PubMed ID: 1638825
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells].
Kuroso K; Isogai N; Koike K; Fukutake K; Fujimaki M
Rinsho Byori; 1992 Dec; 40(12):1281-6. PubMed ID: 1307633
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibrin D-dimer in pregnancies complicated by partial placental abruption.
Neiger R; Krohn HJ; Trofatter MO
Tenn Med; 1997 Oct; 90(10):403-5. PubMed ID: 9323905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
